The Specificity of Epizootic and Epidemiological Processes in Natural Foci of Hemorrhagic Fever with Renal Syndrome and Tick-Borne Encephalitis in Russia, as the Basis for the Prospects of Creating a Combined Vaccine for the Prevention of These Infections
Evgeniy Tkachenko,
Alexandra Balkina,
Dmitriy Trankvilevsky,
Nadezda Kolyasnikova,
Rostislav Teodorovich,
Mikhail Vorovich,
Yulia Popova,
Svetlana Kurashova,
Maria Egorova,
Alla Belyakova,
Petr Tkachenko,
Aydar Ishmukhametov,
Tamara Dzagurova
Affiliations
Evgeniy Tkachenko
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia
Alexandra Balkina
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia
Dmitriy Trankvilevsky
Federal Center of Hygiene and Epidemiology, Moscow 117105, Russia
Nadezda Kolyasnikova
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia
Rostislav Teodorovich
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia
Mikhail Vorovich
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia
Yulia Popova
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia
Svetlana Kurashova
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia
Maria Egorova
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia
Alla Belyakova
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia
Petr Tkachenko
Department of Internal Disease Propaedeutics, Sechenov First Moscow State Medical University, Moscow 119991, Russia
Aydar Ishmukhametov
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia
Tamara Dzagurova
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia
Hemorrhagic fever with renal syndrome (HFRS) and tick-borne encephalitis (TBE) are the most common viral diseases in Russia. HFRS is caused by six different types of hantaviruses: Hantaan, Amur, Seoul, Puumala, Kurkino, and Sochi, which are transmitted to humans through small mammals of the Muridae and Cricetidae families. TBE is caused by viruses belonging to five different phylogenetic subtypes. The similarities in the ecology of HFRS and TBE pathogens is presented here. Hantavirus-infected small mammals can transmit the virus to uninfected animals, and ticks can also transmit hantavirus to other ticks and mammals. Hantavirus transmission from ticks to humans is possible only hypothetically based on indirect data. Over the past 23 years, 164,582 cases of HFRS (4.9 per 105 people) and 71,579 cases of TBE (2.5 per 105 people) were registered in Russia. The mortality rate was 0.4% (668 cases) in HFRS and 1.6% deaths (1136 cases) in TBE. There were 4030 HFRS (2.5%) and 9414 TBE (13%) cases in children under 14 years old. HFRS and TBE cases were registered in 42 out of 85 Russian regions; in 18—only HFRS, in 13—only TBE, and 12 had no reported cases. The prospects of applying a combined vaccine for HFRS and TBE prevention are shown in this paper.